SEC 13F Intelligence

Managers / Q2 2023 · view latest →

Cheyne Capital Management (UK) LLP

CIK 0001390457 · STORNOWAY HOUSE, 13 CLEVELAND ROW, LONDON, X0, SW1A 1DH · 011-44(0)2070317450

Reported Value
$27M
Q2 2023
Positions
19
Filings on Record
22
2019–present window
Filed
Jul 14, 2023
original filing

Summary

Cheyne Capital Management (UK) LLP reported $27M in U.S.-listed holdings across 19 positions for Q2 2023.

The portfolio is heavily concentrated: LLY alone accounts for 25.9% of reported value.

Compared with Q1 2023, the fund opened 9 new positions and exited 12.

Portfolio Metrics

Turnover
+33.2%
vs prior filed quarter
Top-10 Concentration
+89.1%
share of reported value
Largest Position
+25.9%
Lilly Eli
New / Exited
9 / 12
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $106MQ4 ’18Q1 ’19: $107MQ2 ’19: $138MQ3 ’19: $158MQ3 ’19Q4 ’19: $165MQ1 ’20: $97MQ2 ’20: $148MQ2 ’20Q3 ’20: $203MQ4 ’20: $198MQ1 ’21: $158MQ1 ’21Q2 ’21: $220MQ3 ’21: $168MQ4 ’21: $154MQ4 ’21Q1 ’22: $159MQ2 ’22: $118MQ3 ’22: $47MQ3 ’22Q4 ’22: $57MQ1 ’23: $32MQ2 ’23: $27MQ2 ’23Q3 ’23: $35MQ4 ’23: $28Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 78.8%ADR: 10.4%Other: 3.5%ETP: 3.3%Equity WRT: 2.1%US DOMESTIC: 1.9%
  • Common Stock · 78.8% · $21M
  • ADR · 10.4% · $3M
  • Other · 3.5% · $940,681
  • ETP · 3.3% · $891,825
  • Equity WRT · 2.1% · $578,460
  • US DOMESTIC · 1.9% · $510,306

Quarter-over-Quarter Changes full breakdown →

vs Q1 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SSENTINELONE INCNEW+148.0K148.0K+$2M$2M
FTCHQFARFETCH LTDNEW+359.9K359.9K+$2M$2M
IQVIQVIA HLDGS INCNEW+4.8K4.8K+$1M$1M
KMIKINDER MORGAN INC DELNEW+60.0K60.0K+$1M$1M
LABORATORY CORP AMER HLDGSNEW+2.2K2.2K+$530,926$530,926
KRKROGER CONEW+11.0K11.0K+$517,000$517,000
SEA LTDNEW+500.0K500.0K+$510,306$510,306
RAPT THERAPEUTICS INCNEW+20.0K20.0K+$374,000$374,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2023

17 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1LLYLILLY ELI & COhistory →COM25.85%$7M15.0K
2OXYOCCIDENTAL PETE CORPCOM · *W EXP 08/03/20213.72%$4M69.0K
3SESEA LTDSPONSORD ADS · NOTE 2.375%12/012.32%$3M548.8K
4SSENTINELONE INChistory →CL A8.24%$2M148.0K
5FTCHQFARFETCH LTDhistory →ORD SH CL A8.01%$2M359.9K
6SUSUNCOR ENERGY INC NEWhistory →COM5.00%$1M46.3K
7NENOBLE CORP PLChistory →ORD SHS A4.89%$1M32.1K
8IQVIQVIA HLDGS INChistory →COM3.98%$1M4.8K
9KMIKINDER MORGAN INC DELhistory →COM3.81%$1M60.0K
10EWZISHARES INChistory →MSCI BRAZIL ETF3.29%$891,82527.5K
11UBERUBER TECHNOLOGIES INChistory →COM3.18%$863,40020.0K
12LABORATORY CORP AMER HLDGSCOM NEW1.96%$530,9262.2K
13KRKROGER COhistory →COM1.91%$517,00011.0K
14PAASPAN AMERN SILVER CORPhistory →COM1.65%$449,06430.8K
15RAPT THERAPEUTICS INCCOM1.38%$374,00020.0K
16WBDWARNER BROS DISCOVERY INCCOM SER A0.69%$188,10015.0K
17MAGENTA THERAPEUTICS INCCOM0.13%$35,75547.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2023$28M15Feb 12, 202413F-HRchanges · EDGAR ↗
Q3 2023$35M24Oct 27, 202313F-HRchanges · EDGAR ↗
Q2 2023$27M19Jul 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$32M22May 3, 202313F-HRchanges · EDGAR ↗
Q4 2022$57M59Feb 10, 202313F-HRchanges · EDGAR ↗
Q3 2022$47M35Nov 10, 2022RESTATEMENTchanges · EDGAR ↗
Q2 2022$118M108Aug 5, 202213F-HRchanges · EDGAR ↗
Q1 2022$159M142May 10, 202213F-HRchanges · EDGAR ↗
Q4 2021$154M125Jan 26, 202213F-HRchanges · EDGAR ↗
Q3 2021$168M112Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$220M114Aug 12, 202113F-HRchanges · EDGAR ↗
Q1 2021$158M100May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$198M88Feb 10, 202113F-HRchanges · EDGAR ↗
Q3 2020$203M57Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$148M46Aug 12, 202013F-HRchanges · EDGAR ↗
Q1 2020$97M40May 7, 202013F-HRchanges · EDGAR ↗
Q4 2019$165M43Feb 12, 202013F-HRchanges · EDGAR ↗
Q3 2019$158M40Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$138M42Aug 8, 201913F-HRchanges · EDGAR ↗
Q1 2019$107M35May 10, 201913F-HRchanges · EDGAR ↗
Q4 2018$106M35Feb 5, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.